Alvotech (ALVOW) Stock: Why It Moved Today
Updated Oct 23, 3:50 PM ET · latest trade in feed Oct 23, 3:45 PM ET (Finnhub)
Updated Oct 23, 2026, 9:44 AM ET · intraday price
- Latest session (Fri Oct 23): $0.45, +$0.00 (+0.07%).
- Latest SEC filing: 6-K on Oct 20, 2026 — foreign issuer report.
Sector peers moving today (Other):BOT +4.79%DXYZ +4.72%GUT -2.28%GAB -2.11%RVT -1.14%
Moderna (MRNA)Amgen (AMGN)Gilead Sciences (GILD)Twist Bioscience (TWST)Argenx Se (ARGX)Revolution Medicines (RVMD)
ALVOW is flat (+0.1%) to $0.45. Trading at $0.45 (intraday, 9:44 AM ET), +0.07% vs the prior close of $0.45. Day range $0.45–$0.45, opened at $1.52.
Why Did ALVOW Stock Move Today?
A plain-English, data-only note for every US trading day (today's note updates every 2 hours while the market is open). Newest first; older days stay archived below.
Oct 23, 2026 — ALVOW is flat (+0.1%) to $0.45
- Trading at $0.45 (intraday, 9:44 AM ET), +0.07% vs the prior close of $0.45. Day range $0.45–$0.45, opened at $1.52.
- 52-week range $0.45–$0.45; the current price sits at 75% of that range, 0.0% below the 52-week high.
ALVOW bull case vs bear case (from the data)
- No clear positive signal in the price trend, filings or insider data right now.
- Thin trading (under $2M a day on average) can mean wide bid/ask spreads.
Latest ALVOW SEC 8-K & 10-Q Filings
Every SEC filing by or about ALVOW in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 20, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Oct 14, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Oct 7, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Oct 5, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 31, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 21, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 19, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 29, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 1, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jun 30, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Things to know before you trade ALVOW
- How much it moves: over the last 20 sessions the average daily move was 0.07% (largest 0.1%). That is a relatively calm stock.
- Liquidity: about 500 shares (≈$225) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.45 vs a range of $0.45–$0.45 (75% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 6-K Oct 20, 2026; 6-K Oct 14, 2026; 6-K Oct 7, 2026.
- Listing: Nasdaq · industry: Biological Products, (No Diagnostic Substances).
ALVOW market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 1.52 | 0.45 | 0.45 | 0.45 | 1.00K |
| Oct 6, 2026 | 1.52 | 0.45 | 0.45 | 0.45 | 0 |
About Alvotech
Alvotech (ALVOW) is listed on the Nasdaq and classified by the SEC under “Biological Products, (No Diagnostic Substances)”. Its business address is in LUXEMBOURG, Luxembourg. State of incorporation: Luxembourg. Fiscal year ends December 31. SEC CIK 1898416.
ALVOW board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
ALVOW financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $—, total liabilities $—, cash $—.
ALVOW earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Biological Products, (No Diagnostic Substances)
Moderna (MRNA)Amgen (AMGN)Gilead Sciences (GILD)Twist Bioscience (TWST)Argenx Se (ARGX)Revolution Medicines (RVMD)Kodiak Sciences (KOD)Biogen (BIIB)Halozyme Therapeutics (HALO)Vaxcyte (PCVX)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Space Exploration Technologies (SPCX)Meta Platforms (META)Tesla (TSLA)Apple (AAPL)Sandisk (SNDK)AMD (AMD)Microsoft (MSFT)Intel (INTC)Amazon (AMZN)
More on ALVOW
Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: intraday data as of Oct 23, 2026, 9:44 AM ET. Filings: SEC EDGAR. Refreshed every 2 hours during US market hours.